The identification of a novel splicing mutation in C1qB in a Japanese family with C1q deficiency: A case report

Yousuke Higuchi, Junya Shimizu, Michiyo Hatanaka, Etsuko Kitano, Hajime Kitamura, Hidetoshi Takada, masataka ishimura, Toshiro Hara, Osamu Ohara, Kenji Asagoe, Toshihide Kubo

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

C1q deficiency is a rare disease that is associated with a high probability of developing systemic lupus erythematosus. We report a 4-year-old Japanese girl who presented with fever, facial erythema, joint pain, and oral ulceration. Complement deficiencies were suspected because of her persistent hypocomplementemia and normal levels of the complement proteins C3 and C4. We identified a novel homozygous splicing mutation in the C1qB gene, c.187 + 1G > T, which is the first mutation to be confirmed in a Japanese individual. Because treatment with steroids and immunosuppressive drugs was not effective, we commenced use of fresh frozen plasma to provide C1q supplements. Currently, the patient remains almost asymptomatic, and we are attempting to control the drug dosage and administration intervals of fresh frozen plasma.

Original languageEnglish
Article number41
JournalPediatric Rheumatology
Volume11
Issue number1
DOIs
Publication statusPublished - Oct 28 2013

Fingerprint

Complement C4
Mutation
Complement C3
Drug and Narcotic Control
Arthralgia
Erythema
Immunosuppressive Agents
Rare Diseases
Systemic Lupus Erythematosus
Complement System Proteins
Fever
Steroids
Pharmaceutical Preparations
Genes
Therapeutics

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Rheumatology
  • Immunology and Allergy

Cite this

Higuchi, Y., Shimizu, J., Hatanaka, M., Kitano, E., Kitamura, H., Takada, H., ... Kubo, T. (2013). The identification of a novel splicing mutation in C1qB in a Japanese family with C1q deficiency: A case report. Pediatric Rheumatology, 11(1), [41]. https://doi.org/10.1186/1546-0096-11-41

The identification of a novel splicing mutation in C1qB in a Japanese family with C1q deficiency : A case report. / Higuchi, Yousuke; Shimizu, Junya; Hatanaka, Michiyo; Kitano, Etsuko; Kitamura, Hajime; Takada, Hidetoshi; ishimura, masataka; Hara, Toshiro; Ohara, Osamu; Asagoe, Kenji; Kubo, Toshihide.

In: Pediatric Rheumatology, Vol. 11, No. 1, 41, 28.10.2013.

Research output: Contribution to journalArticle

Higuchi, Y, Shimizu, J, Hatanaka, M, Kitano, E, Kitamura, H, Takada, H, ishimura, M, Hara, T, Ohara, O, Asagoe, K & Kubo, T 2013, 'The identification of a novel splicing mutation in C1qB in a Japanese family with C1q deficiency: A case report', Pediatric Rheumatology, vol. 11, no. 1, 41. https://doi.org/10.1186/1546-0096-11-41
Higuchi, Yousuke ; Shimizu, Junya ; Hatanaka, Michiyo ; Kitano, Etsuko ; Kitamura, Hajime ; Takada, Hidetoshi ; ishimura, masataka ; Hara, Toshiro ; Ohara, Osamu ; Asagoe, Kenji ; Kubo, Toshihide. / The identification of a novel splicing mutation in C1qB in a Japanese family with C1q deficiency : A case report. In: Pediatric Rheumatology. 2013 ; Vol. 11, No. 1.
@article{05e79e9b4c554708b7c63aa1e113a29e,
title = "The identification of a novel splicing mutation in C1qB in a Japanese family with C1q deficiency: A case report",
abstract = "C1q deficiency is a rare disease that is associated with a high probability of developing systemic lupus erythematosus. We report a 4-year-old Japanese girl who presented with fever, facial erythema, joint pain, and oral ulceration. Complement deficiencies were suspected because of her persistent hypocomplementemia and normal levels of the complement proteins C3 and C4. We identified a novel homozygous splicing mutation in the C1qB gene, c.187 + 1G > T, which is the first mutation to be confirmed in a Japanese individual. Because treatment with steroids and immunosuppressive drugs was not effective, we commenced use of fresh frozen plasma to provide C1q supplements. Currently, the patient remains almost asymptomatic, and we are attempting to control the drug dosage and administration intervals of fresh frozen plasma.",
author = "Yousuke Higuchi and Junya Shimizu and Michiyo Hatanaka and Etsuko Kitano and Hajime Kitamura and Hidetoshi Takada and masataka ishimura and Toshiro Hara and Osamu Ohara and Kenji Asagoe and Toshihide Kubo",
year = "2013",
month = "10",
day = "28",
doi = "10.1186/1546-0096-11-41",
language = "English",
volume = "11",
journal = "Pediatric Rheumatology",
issn = "1546-0096",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - The identification of a novel splicing mutation in C1qB in a Japanese family with C1q deficiency

T2 - A case report

AU - Higuchi, Yousuke

AU - Shimizu, Junya

AU - Hatanaka, Michiyo

AU - Kitano, Etsuko

AU - Kitamura, Hajime

AU - Takada, Hidetoshi

AU - ishimura, masataka

AU - Hara, Toshiro

AU - Ohara, Osamu

AU - Asagoe, Kenji

AU - Kubo, Toshihide

PY - 2013/10/28

Y1 - 2013/10/28

N2 - C1q deficiency is a rare disease that is associated with a high probability of developing systemic lupus erythematosus. We report a 4-year-old Japanese girl who presented with fever, facial erythema, joint pain, and oral ulceration. Complement deficiencies were suspected because of her persistent hypocomplementemia and normal levels of the complement proteins C3 and C4. We identified a novel homozygous splicing mutation in the C1qB gene, c.187 + 1G > T, which is the first mutation to be confirmed in a Japanese individual. Because treatment with steroids and immunosuppressive drugs was not effective, we commenced use of fresh frozen plasma to provide C1q supplements. Currently, the patient remains almost asymptomatic, and we are attempting to control the drug dosage and administration intervals of fresh frozen plasma.

AB - C1q deficiency is a rare disease that is associated with a high probability of developing systemic lupus erythematosus. We report a 4-year-old Japanese girl who presented with fever, facial erythema, joint pain, and oral ulceration. Complement deficiencies were suspected because of her persistent hypocomplementemia and normal levels of the complement proteins C3 and C4. We identified a novel homozygous splicing mutation in the C1qB gene, c.187 + 1G > T, which is the first mutation to be confirmed in a Japanese individual. Because treatment with steroids and immunosuppressive drugs was not effective, we commenced use of fresh frozen plasma to provide C1q supplements. Currently, the patient remains almost asymptomatic, and we are attempting to control the drug dosage and administration intervals of fresh frozen plasma.

UR - http://www.scopus.com/inward/record.url?scp=84886121183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886121183&partnerID=8YFLogxK

U2 - 10.1186/1546-0096-11-41

DO - 10.1186/1546-0096-11-41

M3 - Article

AN - SCOPUS:84886121183

VL - 11

JO - Pediatric Rheumatology

JF - Pediatric Rheumatology

SN - 1546-0096

IS - 1

M1 - 41

ER -